Isolation, Molecular Characterization, and Pathogenicity Evaluation of a Genotype GI Feline Calicivirus Isolate

Feline calicivirus (FCV) is a highly heterogeneous pathogen and a major cause of feline upper respiratory tract disease, highlighting the need for continuous surveillance of its genetic diversity and pathogenic characteristics. In this study, we isolated and comprehensively characterized a newly isolated FCV strain, HN/ZZ/2025, from cats at a feline trading market in Zhengzhou, China, and systematically evaluated its molecular features, in vitro replication characteristics, physicochemical properties, and pathogenicity in cats. Phylogenetic analysis classified HN/ZZ/2025 as genotype GI. The isolate replicated efficiently in CRFK, F81, and Fc3Tg cells, reaching peak titers of 107.18, 107.50, and 105.89 TCID50/0.1 mL, respectively, and exhibited typical calicivirus-like particles with diameters of 35–40 nm. Complete genome analysis showed that HN/ZZ/2025 shared the highest nucleotide and amino acid sequence identities of 85.7% and 62.8%, respectively, with the closely related Chinese FCV strain CH-JL4, and revealed distinct amino acid variations within the hypervariable E region of the VP1 capsid protein. Experimental infection of cats (n = 3/group) resulted in pyrexia, with rectal temperatures reaching 39.8–40.2 °C, weight loss, oral ulceration, and persistent viral RNA shedding from 1 to 21 days post-infection. Viral RNA and VP1 antigen were detected in the lungs, trachea, kidneys, and spleen, indicating systemic dissemination and broad tissue distribution. Although no mortality occurred during the observation period, the observed clinical signs, viral dissemination, and histopathological lesions indicate that HN/ZZ/2025 is capable of causing clinically evident disease in experimentally infected cats. These findings provide useful insights into the molecular epidemiology, tissue tropism, and host–virus interactions of circulating FCV strains and establish HN/ZZ/2025 as a useful isolate for future studies of FCV genetic diversity and pathogenesis.